Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Diagn Microbiol Infect Dis. 2011 Dec;71(4):470-3. doi: 10.1016/j.diagmicrobio.2011.09.002. Epub 2011 Oct 21.
Oritavancin exhibited lower MIC(50) values (0.03 and 0.5 mg/L) than comparators against methicillin-resistant Staphylococcus aureus (MRSA, n = 50) and vancomycin-intermediate SA strains (n = 60). At subtherapeutic concentrations, oritavancin demonstrated rapid (within 9 h) and concentration-dependent bactericidal activity against daptomycin nonsusceptible (DNS) MRSA. Further investigations are warranted to determine the therapeutic potential of oritavancin against DNS MRSA.
奥他万古霉素对耐甲氧西林金黄色葡萄球菌(MRSA,n = 50)和万古霉素中介金黄色葡萄球菌(n = 60)的 MIC50 值(0.03 和 0.5 mg/L)均低于对照药物。在低于治疗浓度时,奥他万古霉素对达托霉素不敏感的耐甲氧西林金黄色葡萄球菌(DNS-MRSA)具有快速(9 小时内)和浓度依赖性杀菌活性。需要进一步研究来确定奥他万古霉素治疗 DNS-MRSA 的潜力。